Own CSL shares? Here’s what’s in the development pipeline

CSL Ltd (ASX: CSL) shares have gained 7% since the S&P/ASX 200 Index (ASX: XJO) listed biotech share held its annual research and development (R&D) briefing on 19 October.

Below, we take a look at what’s in that pipeline.

What is the ASX 200 biotech…